Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

NCT07698886 is registered in ClinicalTrials.gov with KTH Biopharma as lead sponsor.

NCT NCT07698886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Lead sponsor
KTH Biopharma
Phase
Phase 2
Overall status
Recruiting
Start date
July 16, 2026
Completion date
September 15, 2027
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genital warts, hpv (human papillomavirus)-associated